Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)
UK Utility Study in Diffuse Large B-Cell Lymphoma
UK Utility Study in Diffuse Large B-Cell Lymphoma
Sponsor study identifier
observational
91
1 country
1
Study Start
May 31, 2016
Actual (reported)Primary Completion
October 31, 2016
Actual (reported)Study Completion
October 31, 2016
Actual (reported)This study is a prospective, cross-sectional survey to be administered to real patients in remission from DLBCL using a 15-minute postal or online survey. The project is designed to describe the impact of DLBCL remission on health utility and quality of life. Data collection will occur over a 4-month period.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 31, 2016
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 10, 2016
Actual (reported)March 15, 2016
Actual (reported)May 31, 2016
Actual (reported)October 31, 2016
Actual (reported)October 31, 2016
Actual (reported)Health-Related Quality of Life According to European Quality of Life 5-Dimension 5-Level (EQ-5D-5L) Score
Up to 4 months of data collection
A cohort of approximately 100 patients in first remission with DLBCL will complete questionnaires through a 15-minute postal or online survey.
Approximately 100 patients in first remission with DLBCL will be recruited from online advertisements and a specialist medical recruitment agency to complete study-administered questionnaires.
PH Associates - an OPen Health Company
Marlow, SL7 2FF, United Kingdom
Clinical Trials
Hoffmann-La Roche
91 participants (actual enrollment reported by the registry).
First Submitted
March 10, 2016
First Posted
March 15, 2016
Study Start
May 31, 2016
Actual (reported)Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL
Contact the study team to confirm eligibility.
Primary Completion
October 31, 2016
Actual (reported)Study Completion
October 31, 2016
Actual (reported)Last Updated
April 20, 2017
Record last verified: 2017-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: